Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma: results from the randomized phase III SHARP trial - Llovet,J.; Peña,C.; Shan,M.; Lathia,C.; Bruix,J. (J Hepatol, 2009)